March 25, 2008 - -A microRNA (miRNA) molecule known as let-7 substantially reduced cancer growth in multiple mouse models of lung cancer as reported by researchers at Yale University School of Medicine and Asuragen, Inc. in the journal Cell Cycle. Cancer afflicts 1.5 million people a year in the United States alone, and lung cancer is the most common and deadly form of cancer worldwide. 
This study indicates a direct role for a miRNA in cancer progression and introduces a new therapeutic paradigm that features the treatment of cancer with a naturally occurring small RNA... [PDF] Asuragen's Press Release - [PDF] Mirna Therapeutic's Press Release -
